{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "MD simulations", "MM-PBSA", "docking", "main protease", "molecular fingerprints", "structural similarity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35805916", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "21"}], "Language": ["eng"], "ELocationID": ["6912", "10.3390/ijms23136912"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "21"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease.", "Abstract": {"AbstractText": ["In continuation of our antecedent work against COVID-19, three natural compounds, namely, Luteoside C (<b>130</b>), Kahalalide E (<b>184</b>), and Streptovaricin B (<b>278</b>) were determined as the most promising SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitors among 310 naturally originated antiviral compounds. This was performed via a multi-step in silico method. At first, a molecular structure similarity study was done with <b>PRD_002214</b>, the co-crystallized ligand of M<sup>pro</sup> (PDB ID: 6LU7), and favored thirty compounds. Subsequently, the fingerprint study performed with respect to <b>PRD_002214</b> resulted in the election of sixteen compounds (<b>7</b>, <b>128</b>, <b>130</b>, <b>156</b>, <b>157</b>, <b>158</b>, <b>180</b>, <b>184</b>, <b>203</b>, <b>204</b>, <b>210</b>, <b>237</b>, <b>264</b>, <b>276</b>, <b>277</b>, and <b>278</b>). Then, results of molecular docking versus M<sup>pro</sup> PDB ID: 6LU7 favored eight compounds (<b>128</b>, <b>130</b>, <b>156</b>, <b>180</b>, <b>184</b>, <b>203</b>, <b>204</b>, and <b>278</b>) based on their binding affinities. Then, in silico toxicity studies were performed for the promising compounds and revealed that all of them have good toxicity profiles. Finally, molecular dynamic (MD) simulation experiments were carried out for compounds <b>130</b>, <b>184</b>, and <b>278</b>, which exhibited the best binding modes against M<sup>pro</sup>. MD tests revealed that luteoside C (<b>130</b>) has the greatest potential to inhibit SARS-CoV-2 main protease."]}, "AuthorList": [{"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0002-5871-2639"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbasia, Cairo 11566, Egypt."}], "LastName": "Youssef", "ForeName": "Fadia S", "Initials": "FS"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0003-0893-6703"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": ["0000-0002-9270-6267"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbasia, Cairo 11566, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia."}], "LastName": "Ashour", "ForeName": "Mohamed L", "Initials": "ML"}, {"Identifier": ["0000-0002-6795-4816"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, King Salman International University (KSIU), South Sinai 46612, Egypt."}], "LastName": "El Hassab", "ForeName": "Mahmoud A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo P.O. Box 11562, Egypt."}], "LastName": "Abou-Seri", "ForeName": "Sahar M", "Initials": "SM"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Product Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, Alexandria 21934, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "GrantList": [{"GrantID": "PNURSP2022R116", "Agency": "The Princess Nourah bint Abdulrahman University Researchers Supporting Project, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Nonstructural Proteins"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "Cysteine Endopeptidases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cysteine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Viral Nonstructural Proteins"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 9 February 2022)].  Available online:  https://covid19.who.int/"}, {"Citation": "Alsaif N.A., Taghour M.S., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Elwan A., Elkady H. Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4, 3-a: 3\u2032, 4\u2032-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J. Enzyme Inhib. Med. Chem. 2021;36:1093\u20131114. doi: 10.1080/14756366.2021.1915303.", "ArticleIdList": ["10.1080/14756366.2021.1915303", "PMC8168755", "34056992"]}, {"Citation": "Belal A. 3D-Pharmacophore Modeling, Molecular Docking, and Virtual Screening for Discovery of Novel CDK4/6 Selective Inhibitors. Russ. J. Bioorg. Chem. 2021;47:317\u2013333. doi: 10.1134/S1068162021330013.", "ArticleIdList": ["10.1134/S1068162021330013"]}, {"Citation": "Belal A. Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction. Anti-Cancer Agents Med. Chem. 2018;18:2124\u20132130. doi: 10.2174/1871520618666180409155520.", "ArticleIdList": ["10.2174/1871520618666180409155520", "29629667"]}, {"Citation": "Marrone T.J., Briggs A.J.M., McCammon J.A. Structure-based drug design: Computational advances. Annu. Rev. Pharmacol. Toxicol. 1997;37:71\u201390. doi: 10.1146/annurev.pharmtox.37.1.71.", "ArticleIdList": ["10.1146/annurev.pharmtox.37.1.71", "9131247"]}, {"Citation": "Li N., Wang Y., Li W., Li H., Yang L., Wang J., Mahdy H.A., Mehany A., Jaiash D.A., Santali E.Y. Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3. J. Chem. 2020;2020:1631243. doi: 10.1155/2020/1631243.", "ArticleIdList": ["10.1155/2020/1631243"]}, {"Citation": "Abdel-Aziz H.A., Eldehna W.M., Fares M., Al-Rashood S.T., Al-Rashood K.A., Abdel-Aziz M.M., Soliman D.H. Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. Int. J. Mol. Sci. 2015;16:8719\u20138743. doi: 10.3390/ijms16048719.", "ArticleIdList": ["10.3390/ijms16048719", "PMC4425105", "25903147"]}, {"Citation": "Durrant J.D., McCammon J.A. Molecular dynamics simulations and drug discovery. BMC Biol. 2011;9:71. doi: 10.1186/1741-7007-9-71.", "ArticleIdList": ["10.1186/1741-7007-9-71", "PMC3203851", "22035460"]}, {"Citation": "Hadni H., Elhallaoui M. 2D and 3D-QSAR, molecular docking and ADMET properties in silico studies of azaaurones as antimalarial agents. New J. Chem. 2020;44:6553\u20136565. doi: 10.1039/C9NJ05767F.", "ArticleIdList": ["10.1039/C9NJ05767F"]}, {"Citation": "Yadav D.K., Khan F., Negi A.S. Pharmacophore modeling, molecular docking, QSAR, and in silico ADMET studies of gallic acid derivatives for immunomodulatory activity. J. Mol. Modeling. 2012;18:2513\u20132525. doi: 10.1007/s00894-011-1265-3.", "ArticleIdList": ["10.1007/s00894-011-1265-3", "22038459"]}, {"Citation": "Belal A., Elanany M.A., Santali E.Y., Al-Karmalawy A.A., Aboelez M.O., Amin A.H., Abdellattif M.H., Mehany A.B., Elkady H. Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management. Molecules. 2022;27:3584. doi: 10.3390/molecules27113584.", "ArticleIdList": ["10.3390/molecules27113584", "PMC9182209", "35684529"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Mahdy H.A., Elkady H. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorg. Chem. 2021;110:104807. doi: 10.1016/j.bioorg.2021.104807.", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M.S., Eissa I.H. [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4\u2032, 3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorg. Med. Chem. 2021;30:115958. doi: 10.1016/j.bmc.2020.115958.", "ArticleIdList": ["10.1016/j.bmc.2020.115958", "33360576"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg. Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}, {"Citation": "Zhang W., Pei J., Lai L. Computational multitarget drug design. J. Chem. Inf. Modeling. 2017;57:403\u2013412. doi: 10.1021/acs.jcim.6b00491.", "ArticleIdList": ["10.1021/acs.jcim.6b00491", "28166637"]}, {"Citation": "Youssef M.I., Zhou Y., Eissa I.H., Wang Y., Zhang J., Jiang L., Hu W., Qi J., Chen Z. Tetradecyl 2, 3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochem. Int. 2020;138:104749. doi: 10.1016/j.neuint.2020.104749.", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., Elwan A., Elkaeed E.B. Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg. Chem. 2021;112:104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Alanazi M.M., Eissa I.H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Alasmari A.F., Albassam H., Elkady H., Elwan A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzyme Inhib. Med. Chem. 2021;36:1760\u20131782. doi: 10.1080/14756366.2021.1956488.", "ArticleIdList": ["10.1080/14756366.2021.1956488", "PMC8344243", "34340610"]}, {"Citation": "Alanazi M.M., Alaa E., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Taghour M.S., Eissa I.H. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: Design, synthesis, and in silico studies. J. Enzyme Inhib. Med. Chem. 2021;36:1732\u20131750. doi: 10.1080/14756366.2021.1945591.", "ArticleIdList": ["10.1080/14756366.2021.1945591", "PMC8330740", "34325596"]}, {"Citation": "Sliwoski G., Kothiwale S., Meiler J., Lowe E.W. Computational methods in drug discovery. Pharmacol. Rev. 2014;66:334\u2013395. doi: 10.1124/pr.112.007336.", "ArticleIdList": ["10.1124/pr.112.007336", "PMC3880464", "24381236"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Eissa I.H., Elsehemy I.A., Mostafa A.E., Hegazy M.M., Afifi W.M., Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28:5823\u20135832. doi: 10.1016/j.sjbs.2021.06.044.", "ArticleIdList": ["10.1016/j.sjbs.2021.06.044", "PMC8459052", "34588897"]}, {"Citation": "Han X., Yang Y., Metwaly A.M., Xue Y., Shi Y., Dou D. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J. Ethnopharmacol. 2019;239:111942. doi: 10.1016/j.jep.2019.111942.", "ArticleIdList": ["10.1016/j.jep.2019.111942", "31075380"]}, {"Citation": "Suleimen Y.M., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Liu H.-W., Basnet B.B., Suleimen R.N., Ishmuratova M.Y., Turdybekov K.M., Van Hecke K. Isolation, Crystal Structure, and In Silico Aromatase Inhibition Activity of Ergosta-5, 22-dien-3\u03b2-ol from the Fungus Gyromitra esculenta. J. Chem. 2021;2021:5529786. doi: 10.1155/2021/5529786.", "ArticleIdList": ["10.1155/2021/5529786"]}, {"Citation": "Metwaly A.M., Lianlian Z., Luqi H., Deqiang D. Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules. 2019;24:1856. doi: 10.3390/molecules24101856.", "ArticleIdList": ["10.3390/molecules24101856", "PMC6572638", "31091790"]}, {"Citation": "Metwaly A.M., Wanas A.S., Radwan M.M., Ross S.A., ElSohly M.A. New \u03b1-Pyrone derivatives from the endophytic fungus Embellisia sp. Med. Chem. Res. 2017;26:1796\u20131800. doi: 10.1007/s00044-017-1889-7.", "ArticleIdList": ["10.1007/s00044-017-1889-7"]}, {"Citation": "Yassin A.M., El-Deeb N.M., Metwaly A.M., El Fawal G.F., Radwan M.M., Hafez E.E. Induction of apoptosis in human cancer cells through extrinsic and intrinsic pathways by Balanites aegyptiaca furostanol saponins and saponin-coated silvernanoparticles. Appl. Biochem. Biotechnol. 2017;182:1675\u20131693. doi: 10.1007/s12010-017-2426-3.", "ArticleIdList": ["10.1007/s12010-017-2426-3", "28236195"]}, {"Citation": "Metwaly A.M., Fronczek F.R., Ma G., Kadry H.A., Atef A., Mohammad A.-E.I., Cutler S.J., Ross S.A. Antileukemic \u03b1-pyrone derivatives from the endophytic fungus Alternaria phragmospora. Tetrahedron Lett. 2014;55:3478\u20133481. doi: 10.1016/j.tetlet.2014.04.085.", "ArticleIdList": ["10.1016/j.tetlet.2014.04.085", "PMC5047437", "27708462"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Eissa I.H., Elkaeed E.B., Ali Z., Khan I.A., Falodun A. Antileishmanial Derivatives of Humulene from Asteriscus hierochunticus with in silico Tubulin Inhibition Potential. Rec. Nat. Prod. 2021:150\u2013171."}, {"Citation": "Metwaly A.M., Ghoneim M.M., Musa A. Two new antileishmanial diketopiperazine alkaloids from the endophytic fungus Trichosporum sp. Derpharmachemica. 2015;7:322."}, {"Citation": "Jalmakhanbetova R., Elkaeed E.B., Eissa I.H., Metwaly A.M., Suleimen Y.M. Synthesis and Molecular Docking of Some Grossgemin Amino Derivatives as Tubulin Inhibitors Targeting Colchicine Binding Site. J. Chem. 2021;2021:5586515. doi: 10.1155/2021/5586515.", "ArticleIdList": ["10.1155/2021/5586515"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In vitro and in silico cytotoxic and antibacterial activities of a diterpene from cousinia alata schrenk. J. Chem. 2021;2021:5542455. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Sharaf M.H., El-Sherbiny G.M., Moghannem S.A., Abdelmonem M., Elsehemy I.A., Metwaly A.M., Kalaba M.H. New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) Sci. Rep. 2021;11:4240. doi: 10.1038/s41598-021-82550-4.", "ArticleIdList": ["10.1038/s41598-021-82550-4", "PMC7896049", "33608582"]}, {"Citation": "Liu L., Luo S., Yu M., Metwaly A.M., Ran X., Ma C., Dou D., Cai D. Chemical Constituents of Tagetes patula and Their Neuroprotecting Action. Nat. Prod. Commun. 2020;15:1934578X20974507."}, {"Citation": "Wang Y.-M., Ran X.-K., Riaz M., Yu M., Cai Q., Dou D.-Q., Metwaly A.M., Kang T.-G., Cai D.-C. Chemical constituents of stems and leaves of Tagetespatula L. and its fingerprint. Molecules. 2019;24:3911. doi: 10.3390/molecules24213911.", "ArticleIdList": ["10.3390/molecules24213911", "PMC6864839", "31671631"]}, {"Citation": "Metwaly A.M., Kadry H.A., Atef A., Mohammad A.-E.I., Ma G., Cutler S.J., Ross S.A. Nigrosphaerin A a new isochromene derivative from the endophytic fungus Nigrospora sphaerica. Phytochem. Lett. 2014;7:1\u20135. doi: 10.1016/j.phytol.2013.09.001.", "ArticleIdList": ["10.1016/j.phytol.2013.09.001", "PMC5047436", "27708743"]}, {"Citation": "Eissa I.H., Alesawy M.S., Saleh A.M., Elkaeed E.B., Alsfouk B.A., El-Attar A.-A.M., Metwaly A.M. Ligand and structure-based in silico determination of the most promising SARS-CoV-2 nsp16-nsp10 2\u2032-o-Methyltransferase complex inhibitors among 3009 FDA approved drugs. Molecules. 2022;27:2287. doi: 10.3390/molecules27072287.", "ArticleIdList": ["10.3390/molecules27072287", "PMC9000629", "35408684"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Falodun A. Comprehensive In Silico Screening of the Antiviral Potentialities of a New Humulene Glucoside from Asteriscus hierochunticus against SARS-CoV-2. J. Chem. 2021;2021:5541876. doi: 10.1155/2021/5541876.", "ArticleIdList": ["10.1155/2021/5541876"]}, {"Citation": "Agbowuro A.A., Huston W.M., Gamble A.B., Tyndall J.D. Proteases and protease inhibitors in infectious diseases. Med. Res. Rev. 2018;38:1295\u20131331. doi: 10.1002/med.21475.", "ArticleIdList": ["10.1002/med.21475", "29149530"]}, {"Citation": "Du Q.-S., Wang S.-Q., Zhu Y., Wei D.-Q., Guo H., Sirois S., Chou K.-C. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. Peptides. 2004;25:1857\u20131864. doi: 10.1016/j.peptides.2004.06.018.", "ArticleIdList": ["10.1016/j.peptides.2004.06.018", "PMC7115412", "15501516"]}, {"Citation": "Hegyi A., Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J. Gen. Virol. 2002;83:595\u2013599. doi: 10.1099/0022-1317-83-3-595.", "ArticleIdList": ["10.1099/0022-1317-83-3-595", "11842254"]}, {"Citation": "Liang P.-H. Characterization and inhibition of SARS-coronavirus main protease. Curr. Top. Med. Chem. 2006;6:361\u2013376. doi: 10.2174/156802606776287090.", "ArticleIdList": ["10.2174/156802606776287090", "16611148"]}, {"Citation": "Ullrich S., Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg. Med. Chem. Lett. 2020;30:127377. doi: 10.1016/j.bmcl.2020.127377.", "ArticleIdList": ["10.1016/j.bmcl.2020.127377", "PMC7331567", "32738988"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., Eissa I.H., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Eissa I.H., Khalifa M.M., Elkaeed E.B., Hafez E.E., Alsfouk A.A., Metwaly A.M. In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules. 2021;26:6151. doi: 10.3390/molecules26206151.", "ArticleIdList": ["10.3390/molecules26206151", "PMC8539059", "34684735"]}, {"Citation": "Alesawy M.S., Elkaeed E.B., Alsfouk A.A., Metwaly A.M., Eissa I. In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-Like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies. Molecules. 2021;26:6593. doi: 10.3390/molecules26216593.", "ArticleIdList": ["10.3390/molecules26216593", "PMC8588135", "34771004"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Maggiora G., Vogt M., Stumpfe D., Bajorath J. Molecular similarity in medicinal chemistry: Miniperspective. J. Med. Chem. 2014;57:3186\u20133204. doi: 10.1021/jm401411z.", "ArticleIdList": ["10.1021/jm401411z", "24151987"]}, {"Citation": "Bender A., Glen R.C. Molecular similarity: A key technique in molecular informatics. Org. Biomol. Chem. 2004;2:3204\u20133218. doi: 10.1039/b409813g.", "ArticleIdList": ["10.1039/b409813g", "15534697"]}, {"Citation": "Altamash T., Amhamed A., Aparicio S., Atilhan M. Effect of hydrogen bond donors and acceptors on CO2 absorption by deep eutectic solvents. Processes. 2020;8:1533. doi: 10.3390/pr8121533.", "ArticleIdList": ["10.3390/pr8121533"]}, {"Citation": "Wan Y., Tian Y., Wang W., Gu S., Ju X., Liu G. In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches. RSC Adv. 2018;8:40529\u201340543. doi: 10.1039/C8RA06475J.", "ArticleIdList": ["10.1039/C8RA06475J", "PMC9091378", "35557880"]}, {"Citation": "Turchi M., Cai Q., Lian G. An evaluation of in-silico methods for predicting solute partition in multiphase complex fluids\u2013A case study of octanol/water partition coefficient. Chem. Eng. Sci. 2019;197:150\u2013158. doi: 10.1016/j.ces.2018.12.003.", "ArticleIdList": ["10.1016/j.ces.2018.12.003"]}, {"Citation": "Sullivan K.M., Enoch S.J., Ezendam J., Sewald K., Roggen E.L., Cochrane S. An adverse outcome pathway for sensitization of the respiratory tract by low-molecular-weight chemicals: Building evidence to support the utility of in vitro and in silico methods in a regulatory context. Appl. Vitr. Toxicol. 2017;3:213\u2013226. doi: 10.1089/aivt.2017.0010.", "ArticleIdList": ["10.1089/aivt.2017.0010"]}, {"Citation": "Zhang H., Ren J.-X., Ma J.-X., Ding L. Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier. Mol. Divers. 2019;23:381\u2013392. doi: 10.1007/s11030-018-9882-8.", "ArticleIdList": ["10.1007/s11030-018-9882-8", "30294757"]}, {"Citation": "Escamilla-Guti\u00e9rrez A., Ribas-Aparicio R.M., C\u00f3rdova-Espinoza M.G., Castel\u00e1n-Vega J.A. In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets. Nucleosides Nucleotides Nucleic Acids. 2021;40:798\u2013807. doi: 10.1080/15257770.2021.1951754.", "ArticleIdList": ["10.1080/15257770.2021.1951754", "34323642"]}, {"Citation": "Kaushik A.C., Kumar A., Bharadwaj S., Chaudhary R., Sahi S. Bioinformatics Techniques for Drug Discovery. Springer; Berlin/Heidelberg, Germany: 2018. Ligand-Based Approach for In-silico Drug Designing; pp. 11\u201319."}, {"Citation": "Sheridan R.P., Kearsley S.K. Why do we need so many chemical similarity search methods? Drug Discov. Today. 2002;7:903\u2013911. doi: 10.1016/S1359-6446(02)02411-X.", "ArticleIdList": ["10.1016/S1359-6446(02)02411-X", "12546933"]}, {"Citation": "Bender A., Jenkins J., Scheiber J., Sukuru S.C.K., Glick M., Davies J.W. How similar are similarity searching methods? A principal component analysis of molecular descriptor space. J. Chem. Inf. Model. 2009;49:108\u2013119. doi: 10.1021/ci800249s.", "ArticleIdList": ["10.1021/ci800249s", "19123924"]}, {"Citation": "Moreira D.D.L., Leit\u00e3o G.G. Quantitative determination of liriodenine and moupinamide in five species of Mollinedia by high performance liquid chromatography. Phytochem. Anal. 2001;12:223\u2013225. doi: 10.1002/pca.584.", "ArticleIdList": ["10.1002/pca.584", "11708299"]}, {"Citation": "Shukla R., Singh S., Singh A., Misra K. Two pronged approach for prevention and therapy of COVID-19 (SARS-CoV-2) by a multi-targeted herbal drug, a component of ayurvedic decoction. Eur. J. Integr. Med. 2021;43:101268. doi: 10.1016/j.eujim.2020.101268.", "ArticleIdList": ["10.1016/j.eujim.2020.101268", "PMC7837292", "33520014"]}, {"Citation": "Hiranuma S., Shibata M., Hudlicky T. Studies in cephalotaxus alkaloids. Stereospecific total synthesis of homoharringtonine. J. Org. Chem. 1983;48:5321\u20135326. doi: 10.1021/jo00174a031.", "ArticleIdList": ["10.1021/jo00174a031"]}, {"Citation": "Choy K.-T., Wong A.Y.-L., Kaewpreedee P., Sia S.F., Chen D., Hui K.P.Y., Chu D.K.W., Chan M.C.W., Cheung P.P.-H., Huang X. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antivir. Res. 2020;178:104786. doi: 10.1016/j.antiviral.2020.104786.", "ArticleIdList": ["10.1016/j.antiviral.2020.104786", "PMC7127386", "32251767"]}, {"Citation": "Talapatra S.K., Mallik A.K., Talapatra B. Pongaglabol, a new hydroxyfuranoflavone, and aurantiamide acetate, a dipeptide from the flowers of Pongamia glabra. Phytochemistry. 1980;19:1199\u20131202. doi: 10.1016/0031-9422(80)83083-4.", "ArticleIdList": ["10.1016/0031-9422(80)83083-4"]}, {"Citation": "Yoon C.-S., Kim D.-C., Lee D.-S., Kim K.-S., Ko W., Sohn J.H., Yim J.H., Kim Y.-C., Oh H. Anti-neuroinflammatory effect of aurantiamide acetate from the marine fungus Aspergillus sp. SF-5921: Inhibition of NF-\u03baB and MAPK pathways in lipopolysaccharide-induced mouse BV2 microglial cells. Int. Immunopharmacol. 2014;23:568\u2013574. doi: 10.1016/j.intimp.2014.10.006.", "ArticleIdList": ["10.1016/j.intimp.2014.10.006", "25448500"]}, {"Citation": "Zhou B., Yang Z., Feng Q., Liang X., Li J., Zanin M., Jiang Z., Zhong N. Aurantiamide acetate from Baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-\u03baB signaling pathway in Influenza A virus-infected cells. J. Ethnopharmacol. 2017;199:60\u201367. doi: 10.1016/j.jep.2017.01.038.", "ArticleIdList": ["10.1016/j.jep.2017.01.038", "28119097"]}, {"Citation": "Jha S., Sahu N., Mahato S.B. Production of the alkaloids emetine and cephaeline in callus cultures of Cephaelis ipecacuanha. Planta Med. 1988;54:504\u2013506. doi: 10.1055/s-2006-962530.", "ArticleIdList": ["10.1055/s-2006-962530", "3212076"]}, {"Citation": "Kumar R., Afsar M., Khandelwal N., Chander Y., Riyesh T., Dedar R.K., Gulati B.R., Pal Y., Barua S., Tripathi B.N. Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E. Antivir. Res. 2021;189:105056. doi: 10.1016/j.antiviral.2021.105056.", "ArticleIdList": ["10.1016/j.antiviral.2021.105056", "PMC7943376", "33711336"]}, {"Citation": "Itoh A., Ikuta Y., Baba Y., Tanahashi T., Nagakura N. Ipecac alkaloids from Cephaelis acuminata. Phytochemistry. 1999;52:1169\u20131176. doi: 10.1016/S0031-9422(99)00361-1.", "ArticleIdList": ["10.1016/S0031-9422(99)00361-1", "10643674"]}, {"Citation": "Alrasheid A.A., Babiker M.Y., Awad T.A. Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis. Silico Pharmacol. 2021;9:10. doi: 10.1007/s40203-020-00073-8.", "ArticleIdList": ["10.1007/s40203-020-00073-8", "PMC7787652", "33432283"]}, {"Citation": "El Sayed K.A. Studies in Natural Products Chemistry. Volume 24. Elsevier; Amsterdam, The Netherlands: 2000. Natural products as antiviral agents; pp. 473\u2013572."}, {"Citation": "Lee I.-A., Joh E.-H., Kim D.-H. Arctigenin isolated from the seeds of Arctium lappa ameliorates memory deficits in mice. Planta Med. 2011;77:1525\u20131527. doi: 10.1055/s-0030-1270746.", "ArticleIdList": ["10.1055/s-0030-1270746", "21308615"]}, {"Citation": "Fu L., Xu P., Liu N., Yang Z., Zhang F., Hu Y. Antiviral effect of Arctigenin compound on influenza virus. Tradit. Chin. Drug Res. Clin. Pharmacol. 2008;4:1\u20134."}, {"Citation": "Shen Y.-F., Liu L., Chen W.-C., Hu Y., Zhu B., Wang G.-X. Evaluation on the antiviral activity of arctigenin against spring viraemia of carp virus. Aquaculture. 2018;483:252\u2013262. doi: 10.1016/j.aquaculture.2017.09.001.", "ArticleIdList": ["10.1016/j.aquaculture.2017.09.001", "PMC7126542", "32287458"]}, {"Citation": "P\u00e1ska C., Innocenti G., Kunv\u00e1ri M., L\u00e1szl\u00f3 M., Szil\u00e1gyi L. Lignan production by Ipomoea cairica callus cultures. Phytochemistry. 1999;52:879\u2013883. doi: 10.1016/S0031-9422(99)00304-0.", "ArticleIdList": ["10.1016/S0031-9422(99)00304-0"]}, {"Citation": "Qian X.-J., Jin Y.-S., Chen H.-S., Xu Q.-Q., Ren H., Zhu S.-Y., Tang H.-L., Wang Y., Zhao P., Qi Z.-T. Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81. J. Gen. Virol. 2016;97:1134\u20131144. doi: 10.1099/jgv.0.000432.", "ArticleIdList": ["10.1099/jgv.0.000432", "26879209"]}, {"Citation": "Kernan M.R., Sendl A., Chen J.L., Jolad S.D., Blanc P., Murphy J.T., Stoddart C.A., Nanakorn W., Balick M.J., Rozhon E.J. Two new lignans with activity against influenza virus from the medicinal plant Rhinacanthus nasutus. J. Nat. Prod. 1997;60:635\u2013637. doi: 10.1021/np960613i.", "ArticleIdList": ["10.1021/np960613i", "9214738"]}, {"Citation": "Kernan M.R., Amarquaye A., Chen J.L., Chan J., Sesin D.F., Parkinson N., Ye Z.-J., Barrett M., Bales C., Stoddart C.A. Antiviral phenylpropanoid glycosides from the medicinal plant Markhamia lutea. J. Nat. Prod. 1998;61:564\u2013570. doi: 10.1021/np9703914.", "ArticleIdList": ["10.1021/np9703914", "9599250"]}, {"Citation": "Dimitrova P., Alipieva K., Stojanov K., Milanova V., Georgiev M.I. Plant-derived verbascoside and isoverbascoside regulate Toll-like receptor 2 and 4-driven neutrophils priming and activation. Phytomedicine. 2019;55:105\u2013118. doi: 10.1016/j.phymed.2018.07.013.", "ArticleIdList": ["10.1016/j.phymed.2018.07.013", "30668420"]}, {"Citation": "Martins F.O., Esteves P.F., Mendes G.S., Barbi N.S., Menezes F.S., Romanos M.T. Verbascoside isolated from Lepechinia speciosa has inhibitory activity against HSV-1 and HSV-2 in vitro. Nat. Prod. Commun. 2009;4:1934578X0900401217. doi: 10.1177/1934578X0900401217.", "ArticleIdList": ["10.1177/1934578X0900401217", "20120109"]}, {"Citation": "Imai S., Fujioka S., Nakanishi K., Koreeda M., Kurokawa T. Extraction of ponasterone a and ecdysterone from podocarpaceae and related plants. Steroids. 1967;10:557\u2013565. doi: 10.1016/0039-128X(67)90129-8.", "ArticleIdList": ["10.1016/0039-128X(67)90129-8", "6078804"]}, {"Citation": "Kimura N., Kainuma M., Inoue T., Chan E., Tangah J., Baba K., Oshiro N., Okamoto C. Botany, uses, chemistry and bioactivities of mangrove plants V: Acrostichum aureum and A. speciosum. ISME/GLOMIS Electron. J. 2017;15:1\u20136."}, {"Citation": "Unwalla H.J., Li M.-J., Kim J.D., Li H.T., Ehsani A., Alluin J., Rossi J.J. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA. Nat. Biotechnol. 2004;22:1573\u20131578. doi: 10.1038/nbt1040.", "ArticleIdList": ["10.1038/nbt1040", "15568018"]}, {"Citation": "Pugach P., Ray N., Klasse P.J., Ketas T.J., Michael E., Doms R.W., Lee B., Moore J.P. Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities. Virology. 2009;387:296\u2013302. doi: 10.1016/j.virol.2009.02.044.", "ArticleIdList": ["10.1016/j.virol.2009.02.044", "PMC2674391", "19303620"]}, {"Citation": "Bandara B.R., Jayasinghe L., Karunaratne V., Wannigama G.P., Bokel M., Kraus W., Sotheeswaran S. Ecdysterone from stem of Diploclisia glaucescens. Phytochemistry. 1989;28:1073\u20131075. doi: 10.1016/0031-9422(89)80185-2.", "ArticleIdList": ["10.1016/0031-9422(89)80185-2"]}, {"Citation": "Rinehart K.L., Jr., Gloer J.B., Cook J.C., Jr., Mizsak S.A., Scahill T.A. Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate. J. Am. Chem. Soc. 1981;103:1857\u20131859. doi: 10.1021/ja00397a055.", "ArticleIdList": ["10.1021/ja00397a055"]}, {"Citation": "Rinehart K.L., Gloer J.B., Hughes R.G., Renis H.E., McGovren J.P., Swynenberg E.B., Stringfellow D.A., Kuentzel S.L., Li L.H. Didemnins: Antiviral and antitumor depsipeptides from a Caribbean tunicate. Science. 1981;212:933\u2013935. doi: 10.1126/science.7233187.", "ArticleIdList": ["10.1126/science.7233187", "7233187"]}, {"Citation": "Hamann M.T., Otto C.S., Scheuer P.J., Dunbar D.C. Kahalalides: Bioactive peptides from a marine mollusk Elysiarufescens and its algal diet Bryopsis sp. J. Org. Chem. 1996;61:6594\u20136600. doi: 10.1021/jo960877+.", "ArticleIdList": ["10.1021/jo960877+", "11667527"]}, {"Citation": "Gustafson K.R., Oku N., Milanowski D.J. Antiviral marine natural products. Curr. Med. Chem. Anti-Infect. Agents. 2004;3:233\u2013249. doi: 10.2174/1568012043353919.", "ArticleIdList": ["10.2174/1568012043353919"]}, {"Citation": "Perry N.B., Blunt J.W., Munro M.H., Pannell L.K. Mycalamide A, an antiviral compound from a New Zealand sponge of the genus Mycale. J. Am. Chem. Soc. 1988;110:4850\u20134851. doi: 10.1021/ja00222a067.", "ArticleIdList": ["10.1021/ja00222a067"]}, {"Citation": "Chou K.-C., Wei D.-Q., Zhong W.-Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Commun. 2003;308:148\u2013151. doi: 10.1016/S0006-291X(03)01342-1.", "ArticleIdList": ["10.1016/S0006-291X(03)01342-1", "PMC7111004", "12890493"]}, {"Citation": "Sagar S., Kaur M., Minneman K.P. Antiviral lead compounds from marine sponges. Mar. Drugs. 2010;8:2619\u20132638. doi: 10.3390/md8102619.", "ArticleIdList": ["10.3390/md8102619", "PMC2992996", "21116410"]}, {"Citation": "Ichiba T., Yoshida W.Y., Scheuer P.J., Higa T., Gravalos D.G. Hennoxazoles, bioactive bisoxazoles from a marine sponge. J. Am. Chem. Soc. 1991;113:3173\u20133174. doi: 10.1021/ja00008a056.", "ArticleIdList": ["10.1021/ja00008a056"]}, {"Citation": "Groweiss A., Look S.A., Fenical W. Solenolides, new antiinflammatory and antiviral diterpenoids from a marine octocoral of the genus Solenopodium. J. Org. Chem. 1988;53:2401\u20132406. doi: 10.1021/jo00246a001.", "ArticleIdList": ["10.1021/jo00246a001"]}, {"Citation": "Shivanika C., Kumar D., Ragunathan V., Tiwari P., Sumitha A. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. J. Biomol. Struct. Dyn. 2020;1:585\u2013611.", "ArticleIdList": ["PMC7573242", "32897178"]}, {"Citation": "Blunt J., Hartshorn M., McLennan T., Munro M., Robinson W.T., Yorke S. Thyrsiferol: A squalene-derived metabolite of Laurencia thyrsifera. Tetrahedron Lett. 1978;19:69\u201372. doi: 10.1016/S0040-4039(01)88986-3.", "ArticleIdList": ["10.1016/S0040-4039(01)88986-3"]}, {"Citation": "Rinehart K.L., Shield L.S., Cohen-Parsons M. Antiviral Substances. In: Attaway D.H., Zaborsky O.R., editors. Pharmaceutical and Bioactive Natural Products. Springer; Boston, MA, USA: 1993. pp. 309\u2013342."}, {"Citation": "Palma F.B., Ara\u00fajo M., Urones J., Barcala P., Marcos I., Ligtow A., Gravalos M. Antiviral Activity of Metabolites from the Brown Seaweed Cystoseira usneoides. Planta Med. 1991;57:A19. doi: 10.1055/s-2006-960261.", "ArticleIdList": ["10.1055/s-2006-960261"]}, {"Citation": "Urones J., Araujo M., Palma F.B., Basabe P., Marcos I., Moro R., Lithgow A., Pineda J. Meroterpenes from Cystoseira usneoides II. Phytochemistry. 1992;31:2105\u20132109. doi: 10.1016/0031-9422(92)80372-L.", "ArticleIdList": ["10.1016/0031-9422(92)80372-L"]}, {"Citation": "Baker B.J., Okuda R.K., Yu P.T., Scheuer P.J. Punaglandins: Halogenated antitumor eicosanoids from the octocoral Telesto riisei. J. Am. Chem. Soc. 1985;107:2976\u20132977. doi: 10.1021/ja00296a026.", "ArticleIdList": ["10.1021/ja00296a026"]}, {"Citation": "Mahalaxmi Y., Sathish T., Rao C.S., Prakasham R. Corn husk as a novel substrate for the production of rifamycin B by isolated Amycolatopsis sp. RSP 3 under SSF. Process Biochem. 2010;45:47\u201353. doi: 10.1016/j.procbio.2009.08.001.", "ArticleIdList": ["10.1016/j.procbio.2009.08.001"]}, {"Citation": "Becker Y. Antiviral agents from natural sources. Pharmacol. Ther. 1980;10:119\u2013159. doi: 10.1016/0163-7258(80)90011-X.", "ArticleIdList": ["10.1016/0163-7258(80)90011-X", "6157168"]}, {"Citation": "Milavetz B.I., Carter W.A. Streptovaricins. Pharmacol. Ther. Part A. 1977;1:289\u2013305. doi: 10.1016/0362-5478(77)90019-5.", "ArticleIdList": ["10.1016/0362-5478(77)90019-5"]}, {"Citation": "Arcamone F., Penco S., Orezzi P., Nicolella V., Pirelli A. Structure and synthesis of distamycin A. Nature. 1964;203:1064\u20131065. doi: 10.1038/2031064a0.", "ArticleIdList": ["10.1038/2031064a0", "14223076"]}, {"Citation": "Grunicke H., Puschendorf B., Werchau H. Mechanism of action of distamycin A and other antibiotics with antiviral activity. Rev. Physiol. Biochem. Pharmacol. 1976;75:69\u201396.", "ArticleIdList": ["59940"]}, {"Citation": "Broyles S.S., Kremer M., Knutson B.A. Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis. J. Virol. 2004;78:2137\u20132141. doi: 10.1128/JVI.78.4.2137-2141.2004.", "ArticleIdList": ["10.1128/JVI.78.4.2137-2141.2004", "PMC369444", "14747579"]}, {"Citation": "Chu H., He Q.-X., Wang J., Hu Y., Wang Y.-Q., Lin Z.-H. In silico design of novel benzohydroxamate-based compounds as inhibitors of histone deacetylase 6 based on 3D-QSAR, molecular docking, and molecular dynamics simulations. New J. Chem. 2020;44:21201\u201321210. doi: 10.1039/D0NJ04704J.", "ArticleIdList": ["10.1039/D0NJ04704J"]}, {"Citation": "Ieritano C., Campbell J.L., Hopkins W.S. Predicting differential ion mobility behaviour in silico using machine learning. Analyst. 2021;146:4737\u20134743. doi: 10.1039/D1AN00557J.", "ArticleIdList": ["10.1039/D1AN00557J", "34212943"]}, {"Citation": "Taha M., Ismail N.H., Ali M., Rashid U., Imran S., Uddin N., Khan K.M. Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies. Bioorg. Chem. 2017;71:192\u2013200. doi: 10.1016/j.bioorg.2017.02.005.", "ArticleIdList": ["10.1016/j.bioorg.2017.02.005", "28228228"]}, {"Citation": "Opo F.A., Rahman M.M., Ahammad F., Ahmed I., Bhuiyan M.A., Asiri A.M. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci. Rep. 2021;11:4049. doi: 10.1038/s41598-021-83626-x.", "ArticleIdList": ["10.1038/s41598-021-83626-x", "PMC7892887", "33603068"]}, {"Citation": "Saeed F., Salim N., Abdo A., Hentabli H. Graph-based consensus clustering for combining multiple clusterings of chemical structures. Mol. Inform. 2013;32:165\u2013178. doi: 10.1002/minf.201200110.", "ArticleIdList": ["10.1002/minf.201200110", "27481278"]}, {"Citation": "Elkady H., Elwan A., El-Mahdy H.A., Doghish A.S., Ismail A., Taghour M.S., Elkaeed E.B., Eissa I.H., Dahab M.A., Mahdy H.A. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies. J. Enzyme Inhib. Med. Chem. 2022;37:397\u2013410. doi: 10.1080/14756366.2021.2015343.", "ArticleIdList": ["10.1080/14756366.2021.2015343", "PMC8725875", "34961427"]}, {"Citation": "Alanazi M.M., Elkady H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Al-Hossaini A.M., Alharbi M.A., Eissa I.H., Dahab M.A. Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study. J. Mol. Struct. 2022;1253:132220. doi: 10.1016/j.molstruc.2021.132220.", "ArticleIdList": ["10.1016/j.molstruc.2021.132220"]}, {"Citation": "Alanazi M.M., Elkady H., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Alanazi M.M., Alharbi M.A., Eissa I.H., Dahab M.A. New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Adv. 2021;11:30315\u201330328. doi: 10.1039/D1RA05925D.", "ArticleIdList": ["10.1039/D1RA05925D", "PMC9044819", "35493991"]}, {"Citation": "El-Helby A.G.A., Ayyad R.R., El-Adl K., Elkady H. Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: Design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking. Mol. Divers. 2019;23:283\u2013298. doi: 10.1007/s11030-018-9871-y.", "ArticleIdList": ["10.1007/s11030-018-9871-y", "30168051"]}, {"Citation": "El-Helby A.G.A., Ayyad R.R., Zayed M.F., Abulkhair H.S., Elkady H., El-Adl K. Design, synthesis, in silico ADMET profile and GABA-A docking of novel phthalazines as potent anticonvulsants. Arch. Der Pharm. 2019;352:1800387. doi: 10.1002/ardp.201800387.", "ArticleIdList": ["10.1002/ardp.201800387", "30989729"]}, {"Citation": "Suleimen Y.M., Jose R.A., Suleimen R.N., Ishmuratova M.Y., Toppet S., Dehaen W., Alsfouk A.A., Elkaeed E.B., Eissa I.H., Metwaly A.M. Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from Artemisia glauca. Molecules. 2022;27:2281. doi: 10.3390/molecules27072281.", "ArticleIdList": ["10.3390/molecules27072281", "PMC9000794", "35408682"]}, {"Citation": "Jalmakhanbetova R.I., Suleimen Y.M., Oyama M., Elkaeed E.B., Eissa I., Suleimen R.N., Metwaly A.M., Ishmuratova M.Y. Isolation and in silico anti-COVID-19 main protease (Mpro) activities of flavonoids and a sesquiterpene lactone from Artemisia sublessingiana. J. Chem. 2021;2021:5547013. doi: 10.1155/2021/5547013.", "ArticleIdList": ["10.1155/2021/5547013"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "Biovia  Qsar, Admet and Predictive Toxicology.  [(accessed on 15 February 2022)].  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Elkaeed E.B., Elkady H., Belal A., Alsfouk B.A., Ibrahim T.H., Abdelmoaty M., Arafa R.K., Metwaly A.M., Eissa I.H. Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes. 2022;10:530. doi: 10.3390/pr10030530.", "ArticleIdList": ["10.3390/pr10030530"]}, {"Citation": "Liu X., Shi D., Zhou S., Liu H., Liu H., Yao X. Molecular dynamics simulations and novel drug discovery. Expert Opin. Drug Discov. 2018;13:23\u201337. doi: 10.1080/17460441.2018.1403419.", "ArticleIdList": ["10.1080/17460441.2018.1403419", "29139324"]}, {"Citation": "Li C.-X., Wang H.-B., Oppong D., Wang J.-X., Chen J.-F., Le Y. Excipient-assisted vinpocetine nanoparticles: Experiments and molecular dynamic simulations. Mol. Pharm. 2014;11:4023\u20134035. doi: 10.1021/mp500045t.", "ArticleIdList": ["10.1021/mp500045t", "25244002"]}, {"Citation": "Kumari R., Kumar R., Lynn A. Open Source Drug Discovery Consortium. g_mmpbsa\u2014A GROMACS Tool for High-Throughput MM-PBSA Calculations. J. Chem. Inf. Modeling. 2014;54:1951\u20131962. doi: 10.1021/ci500020m.", "ArticleIdList": ["10.1021/ci500020m", "24850022"]}, {"Citation": "Hagras M., El Deeb M.A., Elzahabi H.S., Elkaeed E.B., Mehany A.B., Eissa I.H. Discovery of new quinolines as potent colchicine binding site inhibitors: Design, synthesis, docking studies, and anti-proliferative evaluation. J. Enzyme Inhib. Med. Chem. 2021;36:640\u2013658. doi: 10.1080/14756366.2021.1883598.", "ArticleIdList": ["10.1080/14756366.2021.1883598", "PMC7889231", "33588683"]}, {"Citation": "Eissa I.H., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., Abdelhady A.A., Elhendawy M.A., Radwan M.M., ElSohly M.A., Mahdy H.A. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorg. Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Alanazi M.M., Mahdy H.A., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Dahab M.A., Eissa I.H. New bis ([1, 2, 4] triazolo) [4, 3-a: 3\u2032, 4\u2032-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorg. Chem. 2021;112:104949. doi: 10.1016/j.bioorg.2021.104949.", "ArticleIdList": ["10.1016/j.bioorg.2021.104949", "34023640"]}, {"Citation": "Abdallah A.E., Alesawy M.S., Eissa S.I., El-Fakharany E.M., Kalaba M.H., Sharaf M.H., Shama N.M.A., Mahmoud S.H., Mostafa A., Al-Karmalawy A.A. Design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening. New J. Chem. 2021;45:16557\u201316571. doi: 10.1039/D1NJ02710G.", "ArticleIdList": ["10.1039/D1NJ02710G"]}, {"Citation": "Yousef R., Sakr H., Eissa I., Mehany A., Metwaly A., Elhendawy M.A., Radwan M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949\u201316964. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "Amer H.H., Alotaibi S.H., Trawneh A.H., Metwaly A.M., Eissa I.H. Anticancer activity, spectroscopic and molecular docking of some new synthesized sugar hydrazones, Arylidene and \u03b1-Aminophosphonate derivatives. Arab. J. Chem. 2021;14:103348. doi: 10.1016/j.arabjc.2021.103348.", "ArticleIdList": ["10.1016/j.arabjc.2021.103348"]}, {"Citation": "Alesawy M.S., Al-Karmalawy A.A., Elkaeed E.B., Alswah M., Belal A., Taghour M.S., Eissa I.H. Design and discovery of new 1, 2, 4-triazolo [4, 3-c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Der Pharm. 2021;354:2000237. doi: 10.1002/ardp.202000237.", "ArticleIdList": ["10.1002/ardp.202000237", "33226150"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "28"}, {"Year": "2022", "Month": "6", "Day": "15"}, {"Year": "2022", "Month": "6", "Day": "15"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "1", "Minute": "10"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35805916", "PMC9266348", "10.3390/ijms23136912", "ijms23136912"]}}], "PubmedBookArticle": []}